23andMe Researchers Identify Genetic Risk Factor for Loss of Smell and Taste in COVID-19 Patients

This new knowledge about the human genome may lead to a new set of biomarkers and clinical laboratory tests for predisposition to this health condition Researchers across the globe are working to understand why some people who become infected with the SARS-CoV-2 coronavirus experience loss of smell (anosmia) and taste (ageusia) often for months following recovery from COVID-19 infection. Now, pathologists and medical laboratory managers will be interested to learn that scientists from DNA...
;